{"filings":[{"id":649436,"accession_number":"0000097745-26-000117","cik":97745,"company_name":"THERMO FISHER SCIENTIFIC INC.","ticker":"TMO","form_type":"8-K","filed_at":"2026-05-26T11:31:03+00:00","items":["5.07"],"status":"ready","headline":"Thermo Fisher say-on-pay fails with 68% votes against at 2026 annual meeting","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["All 11 director nominees elected; top vote-getter Debora L. Spar (314.4M for), lowest Dion J. Weisler (281.8M for).","Advisory say-on-pay proposal failed: 214.5M votes against (68.2%), 99.9M for.","Ratification of PricewaterhouseCoopers as independent auditor for FY2026 passed with 296.9M for.","Annual meeting held May 20, 2026; results filed May 26, 2026."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.15,"market_cap_usd":169537423477.71124,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":100013,"accession_number":"0000097745-26-000086","cik":97745,"company_name":"THERMO FISHER SCIENTIFIC INC.","ticker":"TMO","form_type":"8-K","filed_at":"2026-04-23T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Thermo Fisher Q1 revenue $11.01B (+6% YoY); adjusted EPS $5.44 (+6%)","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q1 revenue $11.01B, up 6% YoY; organic revenue growth 1%.","GAAP EPS $4.43 (+11% YoY); adjusted EPS $5.44 (+6% YoY).","GAAP operating income $1.86B (+9%); adj. operating income $2.40B (+6%), margin 21.8%.","Completed Clario acquisition; repurchased $3.0B stock; increased dividend by 10%.","Strategic collaborations with NVIDIA and SHL Medical; launched Glacios 3 Cryo-TEM and other products."],"consensus_eps_estimate":null,"consensus_eps_actual":4.43,"consensus_revenue_estimate":null,"consensus_revenue_actual":11005000000.0,"consensus_period":"2026-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":169537423477.71124,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":116351,"accession_number":"0000097745-26-000066","cik":97745,"company_name":"THERMO FISHER SCIENTIFIC INC.","ticker":"TMO","form_type":"8-K","filed_at":"2026-03-24T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Thermo Fisher completes acquisition of Clario Holdings; no deal terms disclosed in filing","summary_kind":"llm","event_type":"m_and_a","confidence":"low","bullets":["Acquisition of Clario Holdings, Inc. completed on March 24, 2026.","No purchase price, financing details, or expected synergies provided in the 8-K or press release text.","Clario is a clinical endpoint technology provider; transaction expands Thermo Fisher's clinical research services.","Press release text was not included in the filing; further details may be available separately."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":169537423477.71124,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":116350,"accession_number":"0001140361-26-005014","cik":97745,"company_name":"THERMO FISHER SCIENTIFIC INC.","ticker":"TMO","form_type":"8-K","filed_at":"2026-02-12T23:59:59+00:00","items":["1.01","8.01","9.01"],"status":"ready","headline":"Thermo Fisher issues $3.8B in senior notes to partially fund Clario acquisition","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Issued four tranches: $1B 4.215% Notes due 2031, $750M 4.550% due 2033, $1.3B 4.902% due 2036, $750M 5.546% due 2046.","Net proceeds of ~$3.76B will be used to pay a portion of cash consideration for the pending Clario Holdings acquisition.","Notes are senior unsecured obligations, redeemable at par after respective par call dates.","Underwriters: Deutsche Bank Securities Inc., RBC Capital Markets, SMBC Nikko, Wells Fargo Securities.","Clario acquisition subject to regulatory approvals and customary closing conditions."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":169537423477.71124,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":116349,"accession_number":"0000097745-26-000012","cik":97745,"company_name":"THERMO FISHER SCIENTIFIC INC.","ticker":"TMO","form_type":"8-K","filed_at":"2026-01-29T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Thermo Fisher Q4 rev $12.21B (+7%), adj EPS $6.57 (+8%); FY rev $44.56B (+4%)","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 GAAP diluted EPS $5.21 (+9%); adj EPS $6.57 (+8%); GAAP operating margin 18.5%.","Full-year GAAP EPS $17.74 (+7%); adj EPS $22.87 (+5%); adj operating margin 22.7%.","Revenue growth driven by organic +3% (Q4) and +2% (FY); PPI Business System cited.","Announced $13B M&A in 2025 including Clario deal; returned $3.6B via buybacks/dividends.","2026 financial guidance to be provided on conference call; not included in press release."],"consensus_eps_estimate":null,"consensus_eps_actual":17.74,"consensus_revenue_estimate":null,"consensus_revenue_actual":44556000000.0,"consensus_period":"2025-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":169537423477.71124,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":116348,"accession_number":"0001140361-26-000871","cik":97745,"company_name":"THERMO FISHER SCIENTIFIC INC.","ticker":"TMO","form_type":"8-K","filed_at":"2026-01-12T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Thermo Fisher EVP/COO Lagarde and EVP Lowery to depart; Pettiti promoted to President and COO","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Michel Lagarde, EVP & COO, leaves March 31, 2026; Frederick Lowery, EVP, leaves Feb 28, 2026.","Effective March 1, 2026, Marc N. Casper becomes Chairman and CEO; Gianluca Pettiti promoted to President and COO.","Michael Shafer, EVP, promoted to expanded role reporting directly to CEO.","Departures described as voluntary to pursue other opportunities; organizational restructuring effective March 1, 2026."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":169537423477.71124,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":132805,"accession_number":"0001140361-25-043790","cik":97745,"company_name":"THERMO FISHER SCIENTIFIC INC.","ticker":"TMO","form_type":"8-K","filed_at":"2025-12-01T23:59:59+00:00","items":["1.01","8.01","9.01"],"status":"ready","headline":"Thermo Fisher issues €2.1B in senior notes via finance subsidiary","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Issued €1.0B floating-rate notes due 2027 and €1.1B 3.628% notes due 2035.","Notes fully guaranteed by Thermo Fisher Scientific Inc. on a senior unsecured basis.","Net proceeds of ~€2.09B after underwriting discounts and expenses.","Proceeds for general corporate purposes including M&A, debt repayment, capex, or share buybacks.","Issued by unit Thermo Fisher Scientific (Finance I) B.V.; listed on NYSE under various TMO tickers."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"market_cap_usd":169537423477.71124,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":132804,"accession_number":"0000097745-25-000156","cik":97745,"company_name":"THERMO FISHER SCIENTIFIC INC.","ticker":"TMO","form_type":"8-K","filed_at":"2025-10-29T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Thermo Fisher to acquire Clario Holdings for $8.875B; deal expected to close mid-2026","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["$8.875B cash at closing; additional $125M deferred and up to $400M contingent consideration.","Transaction expected to close mid-2026, subject to regulatory approvals and customary conditions.","The acquisition is structured as a definitive agreement announced on October 29, 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":169537423477.71124,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":132803,"accession_number":"0000097745-25-000150","cik":97745,"company_name":"THERMO FISHER SCIENTIFIC INC.","ticker":"TMO","form_type":"8-K","filed_at":"2025-10-22T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Thermo Fisher Q3 revenue $11.12B (+5%); adjusted EPS $5.79 (+10%)","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $11.12B, +5% reported and +3% organic; GAAP EPS $4.27 vs $4.25 YoY.","Adjusted operating margin 23.3% vs 22.3% YoY; adjusted operating income $2.59B.","Completed acquisitions of Solventum filtration business and Sanofi's Ridgefield fill-finish site.","Repurchased $1.0B of stock; established AI collaboration with OpenAI.","2025 guidance to be updated during earnings call; no specific numbers provided in release."],"consensus_eps_estimate":null,"consensus_eps_actual":12.53,"consensus_revenue_estimate":null,"consensus_revenue_actual":32341000000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":169537423477.71124,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":132802,"accession_number":"0001140361-25-037501","cik":97745,"company_name":"THERMO FISHER SCIENTIFIC INC.","ticker":"TMO","form_type":"8-K","filed_at":"2025-10-07T23:59:59+00:00","items":["1.01","8.01","9.01"],"status":"ready","headline":"Thermo Fisher issues $2.5B senior notes in four tranches due 2031–2037","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Issued $500M 4.200% notes due 2031, $750M 4.473% notes due 2032, $750M 4.794% notes due 2035, and $500M 4.894% notes due 2037.","Net proceeds expected to be ~$2.48B after underwriting discounts and expenses.","Proceeds will be used for general corporate purposes including potential acquisitions, debt repayment, working capital, or share repurchases.","Notes are unsecured and rank equally with existing unsecured unsubordinated debt; redeemable at par after respective par call dates.","Underwriting agreement signed September 30, 2025 with J.P. Morgan, ING, Mizuho, Scotia Capital as representatives."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":169537423477.71124,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":149339,"accession_number":"0000097745-25-000111","cik":97745,"company_name":"THERMO FISHER SCIENTIFIC INC.","ticker":"TMO","form_type":"8-K","filed_at":"2025-09-02T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Thermo Fisher completes acquisition of Solventum's purification and filtration business","summary_kind":"llm","event_type":"m_and_a","confidence":"medium","bullets":["Transaction closed as of September 2, 2025.","Thermo Fisher acquires Solventum's purification and filtration business.","No financial terms or detailed conditions disclosed in the filing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":169537423477.71124,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":149338,"accession_number":"0000097745-25-000095","cik":97745,"company_name":"THERMO FISHER SCIENTIFIC INC.","ticker":"TMO","form_type":"8-K","filed_at":"2025-07-23T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Thermo Fisher CFO Stephen Williamson to retire March 2026; James Meyer named successor","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["CFO Stephen Williamson will retire effective March 31, 2026.","James R. Meyer appointed as SVP and CFO, effective March 1, 2026.","Meyer currently VP, Financial Operations, joined Thermo Fisher in 2009.","Meyer previously worked at PricewaterhouseCoopers.","Transition planned; Williamson supporting until retirement."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":169537423477.71124,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":149337,"accession_number":"0000097745-25-000093","cik":97745,"company_name":"THERMO FISHER SCIENTIFIC INC.","ticker":"TMO","form_type":"8-K","filed_at":"2025-07-23T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Thermo Fisher Q2: rev +3% to $10.85B, GAAP EPS $4.28 (+6%), adj EPS $5.36","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q2 revenue $10.85B (+3% YoY; organic 2%); GAAP diluted EPS $4.28, up 6% from $4.04.","Adjusted EPS $5.36 (vs $5.37); GAAP op margin 16.9% (down 40bps); adj op margin 21.9% (down 40bps).","2025 annual guidance to be updated during today's earnings call.","New product launches: Orbitrap Astral Zoom MS, Krios 5 Cryo-TEM, DynaDrive bioreactor bench scale.","Post-quarter: expanded Sanofi partnership, acquiring Ridgefield, NJ sterile fill-finish site."],"consensus_eps_estimate":null,"consensus_eps_actual":8.26,"consensus_revenue_estimate":null,"consensus_revenue_actual":21219000000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":169537423477.71124,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":168377,"accession_number":"0000097745-25-000069","cik":97745,"company_name":"THERMO FISHER SCIENTIFIC INC.","ticker":"TMO","form_type":"8-K","filed_at":"2025-05-28T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Thermo Fisher say-on-pay vote fails at 2025 annual meeting; all directors elected","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Non-binding advisory vote on executive compensation failed: 201.4M against vs 111.1M for (64.5% against).","All 12 director nominees elected; Marc Casper received 25.7M against (8.2%) and Dion Weisler 41.3M against (13.1%).","Ratification of PwC as independent auditor approved with 295.9M for, 38.1M against.","Shareholder proposal to remove one-year holding period for special meetings rejected: 289.7M against vs 25.7M for."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.15,"market_cap_usd":169537423477.71124,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":168376,"accession_number":"0000097745-25-000066","cik":97745,"company_name":"THERMO FISHER SCIENTIFIC INC.","ticker":"TMO","form_type":"8-K","filed_at":"2025-05-22T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Thermo Fisher grants CEO Casper $60M performance RSU award with TSR-based vesting through 2030","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Target award of 141,538 shares (~$60M) to CEO Marc Casper; cliff vesting May 21, 2030 contingent on TSR vs S&P 500.","Payout: 50% of target at <25th percentile TSR, target at 50th, 125% at 75th; capped at target if absolute TSR negative.","Earned shares deferred and delivered in three equal tranches on 8th, 9th, and 10th anniversaries of grant date.","Non-recurring award; designed to secure Casper's leadership through at least May 2030 and drive long-term shareholder returns."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":169537423477.71124,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":168375,"accession_number":"0000097745-25-000034","cik":97745,"company_name":"THERMO FISHER SCIENTIFIC INC.","ticker":"TMO","form_type":"8-K","filed_at":"2025-04-23T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Thermo Fisher Q1 GAAP EPS $3.98 (+15%), revenue $10.36B; agrees to acquire Solventum biz for $4.1B","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q1 revenue $10.36B (+0.2% YoY); organic growth 1%; GAAP diluted EPS $3.98 (+15%).","Adjusted EPS $5.15 (+1%); adjusted operating margin 21.9% vs 22.0% prior year.","Entered agreement to acquire Solventum's Purification & Filtration Business for $4.1B cash.","Repurchased $2.0B of stock in Q1; increased dividend by 10%.","Launched new products: Vulcan Automated Lab for semiconductors, Olink Reveal kits, and new centrifuges."],"consensus_eps_estimate":null,"consensus_eps_actual":3.98,"consensus_revenue_estimate":null,"consensus_revenue_actual":10364000000.0,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":169537423477.71124,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":185544,"accession_number":"0000097745-25-000016","cik":97745,"company_name":"THERMO FISHER SCIENTIFIC INC.","ticker":"TMO","form_type":"8-K","filed_at":"2025-02-25T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"Thermo Fisher to acquire Solventum's purification and filtration business for $4.1B","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Deal value approximately $4.1 billion in cash.","Expected to close by end of 2025, subject to regulatory approvals and customary conditions.","Acquisition expands Thermo Fisher's purification and filtration capabilities within life sciences.","Solventum is the seller; transaction structured as asset purchase of the business."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":169537423477.71124,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":185543,"accession_number":"0000097745-25-000007","cik":97745,"company_name":"THERMO FISHER SCIENTIFIC INC.","ticker":"TMO","form_type":"8-K","filed_at":"2025-02-19T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Thermo Fisher elects former CVS Health CEO Karen S. Lynch to its board","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Board size increased to 12; Lynch elected effective February 19, 2025, term until 2025 annual meeting.","Lynch, former President and CEO of CVS Health, brings over 30 years of health care experience.","Anticipated to serve on Audit Committee following re-election at 2025 annual meeting.","Will receive standard non-employee director compensation and indemnification agreement."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":169537423477.71124,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":185542,"accession_number":"0000097745-25-000003","cik":97745,"company_name":"THERMO FISHER SCIENTIFIC INC.","ticker":"TMO","form_type":"8-K","filed_at":"2025-01-30T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Thermo Fisher Q4 revenue $11.40B (+5%), adj. EPS $6.10 (+8%)","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 GAAP diluted EPS $4.78 (+14% YoY); adjusted EPS $6.10 (+8% YoY).","Full year 2024 revenue $42.88B (flat YoY); GAAP EPS $16.53 (+7%), adj. EPS $21.86 (+1%).","Q4 GAAP operating margin 17.7% (vs 17.0% YoY); adj. operating margin 23.9% (vs 23.4%).","Returned $4.6B to shareholders in 2024 via buybacks and dividends; completed Olink acquisition.","2025 financial guidance to be provided during earnings call at 8:30 a.m. ET."],"consensus_eps_estimate":null,"consensus_eps_actual":16.53,"consensus_revenue_estimate":null,"consensus_revenue_actual":42879000000.0,"consensus_period":"2024-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":169537423477.71124,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":202128,"accession_number":"0000097745-24-000043","cik":97745,"company_name":"THERMO FISHER SCIENTIFIC INC.","ticker":"TMO","form_type":"8-K","filed_at":"2024-10-23T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Thermo Fisher Q3 revenue flat at $10.60B; adjusted EPS $5.28; raises FY adjusted EPS guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $10.60B, essentially flat versus $10.57B in Q3 2023; organic revenue also flat.","GAAP diluted EPS $4.25 vs $4.42; adjusted EPS $5.28 vs $5.69, both down YoY.","GAAP operating margin 17.3% vs 17.6%; adjusted operating margin 22.3% vs 24.2%.","FY 2024 adjusted EPS guidance raised to $21.35-$22.07 from $21.29-$22.07; revenue guidance unchanged at $42.4-$43.3B.","CEO cites sequential improvement in growth and strong commercial wins."],"consensus_eps_estimate":null,"consensus_eps_actual":11.75,"consensus_revenue_estimate":null,"consensus_revenue_actual":31484000000.0,"consensus_period":"2024-Q3","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":169537423477.71124,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":218171,"accession_number":"0000097745-24-000036","cik":97745,"company_name":"THERMO FISHER SCIENTIFIC INC.","ticker":"TMO","form_type":"8-K","filed_at":"2024-07-24T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Thermo Fisher Q2 GAAP EPS $4.04 (+15%), Adj. EPS $5.37 (+4%), raises FY 2024 guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $10.54B, down 1% YoY; organic revenue -1%, core organic revenue flat.","GAAP operating margin improved to 17.3% from 14.8%; adjusted operating margin 22.3% vs 22.2%.","Completed Olink acquisition post-quarter to extend proteomics capabilities.","Raised FY 2024 revenue guidance to $42.4-43.3B (prev. $42.3-43.3B) and adj. EPS to $21.29-22.07 (prev. $21.14-22.02).","Launched multiple new instruments including Stellar mass spec and biobased bioprocessing film."],"consensus_eps_estimate":null,"consensus_eps_actual":7.5,"consensus_revenue_estimate":null,"consensus_revenue_actual":20886000000.0,"consensus_period":"2024-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":169537423477.71124,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":218170,"accession_number":"0000950157-24-000978","cik":97745,"company_name":"THERMO FISHER SCIENTIFIC INC.","ticker":"TMO","form_type":"8-K","filed_at":"2024-07-10T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Thermo Fisher announces expiration and results of Olink tender offer","summary_kind":"llm","event_type":"m_and_a","confidence":"medium","bullets":["TMO subsidiary Orion Acquisition AB concluded tender offer for all Olink common shares and ADRs.","Press release issued July 10, 2024, reports expiration and results of the previously announced offer.","Tender offer is part of TMO's acquisition of Olink Holding AB (publ).","Exact tender percentages and pricing details are not provided in this filing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":169537423477.71124,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":238134,"accession_number":"0000097745-24-000026","cik":97745,"company_name":"THERMO FISHER SCIENTIFIC INC.","ticker":"TMO","form_type":"8-K","filed_at":"2024-05-24T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Thermo Fisher annual meeting results: all directors elected, say-on-pay passes, simple majority proposal fails","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["All 11 director nominees elected; highest votes for Debora L. Spar (318.2M for) and lowest for Marc N. Casper (291.6M for).","Advisory vote on executive compensation approved with 280.8M for, 35.3M against, 3.0M abstain.","Ratification of PricewaterhouseCoopers as auditor for FY2024 passed with 300.7M for, 36.96M against.","Shareholder proposal to implement simple majority voting rejected: 21.4M for, 296.8M against.","Broker non-votes of 18.9M on director election and executive compensation proposals."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.15,"market_cap_usd":169537423477.71124,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":238133,"accession_number":"0000097745-24-000019","cik":97745,"company_name":"THERMO FISHER SCIENTIFIC INC.","ticker":"TMO","form_type":"8-K","filed_at":"2024-04-24T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Thermo Fisher Q1 rev $10.34B (-3%), GAAP EPS $3.46 (+4%), raises FY guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["GAAP diluted EPS $3.46 vs $3.32 YoY; adjusted EPS $5.11 vs $5.03 (+2%).","Revenue $10.34B, down 3%; organic revenue -4%, core organic -3%.","Raises FY2024 revenue guidance to $42.3-43.3B (prev $42.1-43.3B).","FY2024 adjusted EPS guidance raised to $21.14-22.02 (prev $20.95-22.00).","Repurchased $3.0B of stock in Q1 and increased dividend by 11%."],"consensus_eps_estimate":null,"consensus_eps_actual":3.46,"consensus_revenue_estimate":null,"consensus_revenue_actual":10345000000.0,"consensus_period":"2024-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.82,"calibrated_materiality_score":0.82,"market_cap_usd":169537423477.71124,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":255600,"accession_number":"0000097745-24-000003","cik":97745,"company_name":"THERMO FISHER SCIENTIFIC INC.","ticker":"TMO","form_type":"8-K","filed_at":"2024-01-31T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Q4 revenue $10.89B (-5% YoY), adjusted EPS $5.67 (+5%); guides 2024 revenue $42.1-43.3B","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 GAAP EPS $4.20 (+5% YoY); adjusted EPS $5.67 (+5%); GAAP operating margin 17.0% vs 16.3%.","Full-year 2023 revenue $42.86B (-5% YoY); adjusted EPS $21.55 vs $23.24 in 2022.","Core organic revenue growth -4% in Q4; full-year core organic growth +1%.","2024 guidance: revenue $42.1B-$43.3B, adjusted EPS $20.95-$22.00.","Returned $3.5B to shareholders via buybacks/dividends in 2023; completed acquisitions of Binding Site, CorEvitas, announced Olink."],"consensus_eps_estimate":null,"consensus_eps_actual":15.45,"consensus_revenue_estimate":null,"consensus_revenue_actual":42857000000.0,"consensus_period":"2023-FY","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":169537423477.71124,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":273053,"accession_number":"0001140361-23-056365","cik":97745,"company_name":"THERMO FISHER SCIENTIFIC INC.","ticker":"TMO","form_type":"8-K","filed_at":"2023-12-05T23:59:59+00:00","items":["1.01","8.01","9.01"],"status":"ready","headline":"Thermo Fisher issues $2.5B in senior notes; net proceeds ~$2.48B for general corporate purposes","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Issued $1B of 5.000% notes due 2026, $1B of 5.000% notes due 2029, and $500M of 5.200% notes due 2034.","Net proceeds of approximately $2.48B after underwriting discounts and expenses.","Proceeds may be used for acquisitions, debt repayment, working capital, capital expenditures, or share repurchases.","Notes are unsecured senior obligations ranking equally with existing unsecured debt."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"market_cap_usd":169537423477.71124,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":273052,"accession_number":"0000097745-23-000072","cik":97745,"company_name":"THERMO FISHER SCIENTIFIC INC.","ticker":"TMO","form_type":"8-K","filed_at":"2023-11-07T23:59:59+00:00","items":["5.04","9.01"],"status":"ready","headline":"Thermo Fisher Scientific 401(k) blackout Dec 21 to Jan 14 due to plan admin transition","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["401(k) plan transitioning to a new administrator, causing temporary suspension of participant transactions.","Blackout period expected from 4:00pm ET Dec 21, 2023 through week of Jan 14, 2024.","Participants cannot change contributions, investment allocations, loans, or withdrawals during blackout.","Directors and executive officers prohibited from trading TMO common stock under Regulation BTR during blackout.","Notice sent to directors/executive officers on Nov 7, 2023; shareholders may obtain blackout dates by contacting Corporate Secretary."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":169537423477.71124,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":273051,"accession_number":"0000097745-23-000065","cik":97745,"company_name":"THERMO FISHER SCIENTIFIC INC.","ticker":"TMO","form_type":"8-K","filed_at":"2023-10-25T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Thermo Fisher Q3 revenue $10.57B (-1% YoY); GAAP EPS $4.42 (+17%); acquires Olink for ~$3.1B","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $10.57B, down 1% YoY; core organic revenue grew 1%; COVID testing revenue $0.05B.","GAAP diluted EPS $4.42 (+17% YoY); adjusted EPS $5.69 (+12% YoY).","GAAP operating margin 17.6% (up 160 bps); adjusted operating margin 24.2% (up 200 bps).","Full-year 2023 guidance revised: revenue $42.7B, core organic growth 1%, adjusted EPS $21.50.","Announced agreement to acquire Olink (OLK) for ~$3.1B net; expected close post-quarter."],"consensus_eps_estimate":null,"consensus_eps_actual":11.25,"consensus_revenue_estimate":null,"consensus_revenue_actual":31971000000.0,"consensus_period":"2023-Q3","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":169537423477.71124,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":273050,"accession_number":"0000950157-23-001058","cik":97745,"company_name":"THERMO FISHER SCIENTIFIC INC.","ticker":"TMO","form_type":"8-K","filed_at":"2023-10-17T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Thermo Fisher to acquire Olink for $26/share, ~$3.1B total","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Cash tender offer at $26/ADS, ~74% premium to Oct 16 close; transaction values Olink at ~$3.1B including ~$143M net cash.","Expected close mid-2024; support agreements from >63% of Olink shareholders including largest shareholder Summa Equity.","Olink projected >$200M revenue in 2024 with mid-teens organic growth; expected to be part of Thermo Fisher's Life Sciences Solutions segment.","Transaction expected to be $0.17 dilutive to adjusted EPS in first full year, but $0.10 accretive excluding financing and equity comp.","Thermo Fisher expects ~$125M adjusted operating income from synergies by year five."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":169537423477.71124,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":289886,"accession_number":"0000097745-23-000062","cik":97745,"company_name":"THERMO FISHER SCIENTIFIC INC.","ticker":"TMO","form_type":"8-K/A","filed_at":"2023-09-21T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Thermo Fisher's new director Jenny Johnson appointed to Audit Committee","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Director Jennifer 'Jenny' Johnson appointed to Audit Committee effective September 21, 2023.","Ms. Johnson was elected to the Thermo Fisher Scientific board on July 13, 2023.","This amendment adds committee assignment detail to the prior 8-K disclosure."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"market_cap_usd":169537423477.71124,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":289890,"accession_number":"0001140361-23-039086","cik":97745,"company_name":"THERMO FISHER SCIENTIFIC INC.","ticker":"TMO","form_type":"8-K","filed_at":"2023-08-10T23:59:59+00:00","items":["1.01","8.01","9.01"],"status":"ready","headline":"Thermo Fisher issues $2.95B senior notes, redeems $1B floating-rate notes","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Issued $600M 4.953% notes due 2026, $750M 4.977% notes due 2030, $1B 5.086% notes due 2033, $600M 5.404% notes due 2043.","Net proceeds ~$2.92B; $1B to redeem $500M Floating Rate Notes 2023 and $500M Floating Rate Notes 2024.","Remaining proceeds for general corporate purposes including acquisitions, debt refinancing, or share repurchases.","Concurrently entered into $2.95B Japanese yen cross currency swaps."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":169537423477.71124,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":289889,"accession_number":"0001140361-23-038455","cik":97745,"company_name":"THERMO FISHER SCIENTIFIC INC.","ticker":"TMO","form_type":"8-K","filed_at":"2023-08-08T23:59:59+00:00","items":["7.01"],"status":"ready","headline":"Thermo Fisher redeems $1B floating-rate notes, prices $2.95B new fixed-rate notes","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Redeems $500M floating-rate notes due 2023 and $500M due 2024 on Aug 18 at par plus accrued interest.","Priced $2.95B in new notes: $600M 4.953% due 2026, $750M 4.977% due 2030, $1B 5.086% due 2033, $600M 5.404% due 2043.","New offering expected to close Aug 10, 2023; proceeds to fund the $1.0B redemption."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":169537423477.71124,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":289888,"accession_number":"0000097745-23-000054","cik":97745,"company_name":"THERMO FISHER SCIENTIFIC INC.","ticker":"TMO","form_type":"8-K","filed_at":"2023-07-26T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Thermo Fisher Q2 revenue $10.69B (-3% YoY), GAAP EPS $3.51, cuts FY guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q2 revenue $10.69B, down 3% YoY; core organic growth +2%; COVID testing revenue $0.08B.","GAAP diluted EPS $3.51 (vs $4.22 YoY); adjusted EPS $5.15 (vs $5.51 YoY).","FY 2023 guidance revised: revenue $43.4-44.0B, core organic growth 2-4%, adj. EPS $22.28-22.72.","Announced agreement to acquire CorEvitas for ~$0.9B post-quarter; adds real-world evidence solutions.","CEO cites challenging macro, slower China spend; PPI Business System helping navigate environment."],"consensus_eps_estimate":null,"consensus_eps_actual":6.83,"consensus_revenue_estimate":null,"consensus_revenue_actual":21397000000.0,"consensus_period":"2023-Q2","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":169537423477.71124,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":289887,"accession_number":"0000097745-23-000051","cik":97745,"company_name":"THERMO FISHER SCIENTIFIC INC.","ticker":"TMO","form_type":"8-K","filed_at":"2023-07-13T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Thermo Fisher elects Franklin Resources CEO Jenny Johnson to Board of Directors","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Board increased to 12 members; Jennifer Johnson elected director effective July 13, 2023.","Johnson is President and CEO of Franklin Resources, managing over $1.4 trillion in assets.","She will receive standard non-employee director compensation and indemnification agreement.","No committee assignments made yet; term expires at 2024 annual meeting."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":169537423477.71124,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":310836,"accession_number":"0000097745-23-000042","cik":97745,"company_name":"THERMO FISHER SCIENTIFIC INC.","ticker":"TMO","form_type":"8-K","filed_at":"2023-05-26T23:59:59+00:00","items":["5.02","5.07","9.01"],"status":"ready","headline":"Shareholders approve Amended 2013 Stock Incentive Plan adding 7M shares and 2023 ESPP authorizing 12M shares","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Shareholders approved Amended 2013 Stock Incentive Plan, increasing authorized shares by 7,000,000.","Shareholders approved 2023 Global Employee Stock Purchase Plan, authorizing up to 12,000,000 shares.","All 11 director nominees were elected; advisory say-on-pay approved with ~79% of votes cast.","Appointment of PricewaterhouseCoopers as auditor ratified; advisory vote favored 1-year frequency for future say-on-pay.","All proposals passed at the Annual Meeting held on May 24, 2023."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":169537423477.71124,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":310835,"accession_number":"0001628280-23-013041","cik":97745,"company_name":"THERMO FISHER SCIENTIFIC INC.","ticker":"TMO","form_type":"8-K","filed_at":"2023-04-26T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Thermo Fisher Q1 revenue $10.71B (-9% YoY); GAAP EPS $3.32, adjusted EPS $5.03","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $10.71B, down 9% YoY; core organic growth 6%; COVID testing revenue $0.14B.","GAAP EPS $3.32 vs $5.61 YoY; adjusted EPS $5.03 vs $7.25 YoY.","GAAP operating margin 14.6% vs 23.9%; adjusted operating margin 21.8% vs 29.2%.","Repurchased $3.0B stock, increased dividend 17%, completed acquisition of The Binding Site.","Guidance update to be provided on earnings call."],"consensus_eps_estimate":null,"consensus_eps_actual":3.32,"consensus_revenue_estimate":null,"consensus_revenue_actual":10710000000.0,"consensus_period":"2023-Q1","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":169537423477.71124,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":329453,"accession_number":"0000097745-23-000003","cik":97745,"company_name":"THERMO FISHER SCIENTIFIC INC.","ticker":"TMO","form_type":"8-K","filed_at":"2023-02-01T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Thermo Fisher Q4 revenue $11.45B (+7% YoY), adjusted EPS $5.40; FY2023 guidance: rev $45.3B","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 revenue $11.45B (+7% YoY); GAAP EPS $4.01 (vs $4.17), adjusted EPS $5.40 (vs $6.54).","Full year revenue $44.92B (+15% YoY); GAAP EPS $17.63 (vs $19.46), adjusted EPS $23.24 (vs $25.13).","Core organic revenue growth 14% in Q4 and FY2022; COVID-19 testing revenue $0.37B Q4, $3.11B FY.","FY2023 guidance: revenue ~$45.3B, Core organic growth 7%, adjusted EPS $23.70.","Completed acquisition of The Binding Site for $2.7B shortly after year-end; PPD integration on track."],"consensus_eps_estimate":null,"consensus_eps_actual":17.63,"consensus_revenue_estimate":null,"consensus_revenue_actual":44915000000.0,"consensus_period":"2022-FY","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":169537423477.71124,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":347050,"accession_number":"0001140361-22-042550","cik":97745,"company_name":"THERMO FISHER SCIENTIFIC INC.","ticker":"TMO","form_type":"8-K","filed_at":"2022-11-21T23:59:59+00:00","items":["1.01","8.01","9.01"],"status":"ready","headline":"Thermo Fisher issues €1.25B in 3.200%/3.650% notes due 2026/2034 and $1.2B in 4.800%/4.950% notes due 2027/2032","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Euro offering: €500M 3.200% notes due 2026 and €750M 3.650% notes due 2034; net proceeds ~€1.24B.","USD offering: $600M 4.800% notes due 2027 and $600M 4.950% notes due 2032; net proceeds ~$1.19B.","Proceeds for general corporate purposes, including acquisitions, debt repayment, share repurchases.","Entered into $1.2B Japanese yen cross currency swaps upon closing of USD offering."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":169537423477.71124,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":347049,"accession_number":"0000097745-22-000060","cik":97745,"company_name":"THERMO FISHER SCIENTIFIC INC.","ticker":"TMO","form_type":"8-K","filed_at":"2022-11-14T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Thermo Fisher aligns CEO Marc Casper's equity vesting on retirement with other officers","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Compensation Committee amended equity awards for CEO Marc Casper to align retirement vesting with other officers.","Amended awards include stock options (2017-2022) and time/performance-based RSUs (2020-2022).","Changes provide accelerated vesting upon retirement and extend option exercise to original expiration (except grants within 2 years pre-retirement).","Committee determined alignment is appropriate and in the best interests of the company and stockholders."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":169537423477.71124,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":347048,"accession_number":"0000097745-22-000053","cik":97745,"company_name":"THERMO FISHER SCIENTIFIC INC.","ticker":"TMO","form_type":"8-K","filed_at":"2022-10-26T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Thermo Fisher Q3 revenue $10.68B, GAAP EPS $3.79, adjusted EPS $5.08","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue grew 14% to $10.68B; core organic revenue growth 14%.","GAAP diluted EPS $3.79 vs $4.79 YoY; adjusted EPS $5.08 vs $5.77.","GAAP operating margin 16.0% vs 24.4%; adjusted operating margin 22.2% vs 29.8%.","COVID-19 testing revenue contributed $0.44B.","Company will provide updated 2022 guidance on earnings call."],"consensus_eps_estimate":null,"consensus_eps_actual":13.62,"consensus_revenue_estimate":null,"consensus_revenue_actual":33465000000.0,"consensus_period":"2022-Q3","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":169537423477.71124,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":347047,"accession_number":"0001140361-22-037956","cik":97745,"company_name":"THERMO FISHER SCIENTIFIC INC.","ticker":"TMO","form_type":"8-K","filed_at":"2022-10-20T23:59:59+00:00","items":["1.01","8.01","9.01"],"status":"ready","headline":"Thermo Fisher Scientific issues ¥110 billion of senior notes in six tranches","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Issued ¥22.3B in 0.853% notes due 2025, ¥28.9B in 1.054% notes due 2027, ¥4.7B in 1.279% notes due 2029.","Also issued ¥6.3B in 1.490% notes due 2032, ¥14.6B in 2.069% notes due 2042, and ¥33.3B in 2.382% notes due 2052.","Underwriters include Citigroup Global Markets, Mizuho Securities, MUFG Securities EMEA, and SMBC Nikko Securities America.","Net proceeds estimated at ¥109.1 billion; proceeds for general corporate purposes including acquisitions and debt refinancing.","Notes are unsecured and rank equally with existing unsubordinated debt; change-of-control trigger may require 101% repurchase."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":169537423477.71124,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":363425,"accession_number":"0000097745-22-000044","cik":97745,"company_name":"THERMO FISHER SCIENTIFIC INC.","ticker":"TMO","form_type":"8-K","filed_at":"2022-07-28T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Thermo Fisher Q2 revenue $10.97B (+18% YoY); GAAP EPS $4.22, adjusted EPS $5.51","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $10.97B (+18% YoY); core organic growth 13%; COVID testing revenue $0.63B.","GAAP diluted EPS $4.22 vs $4.61 YoY; adjusted EPS $5.51 vs $5.60 YoY.","Adjusted operating margin 23.7% vs 29.0% YoY; GAAP operating income $2.00B.","Launched new products including Gibco CTS TrueCut Cas9 and Phadia 2500+ series.","Company to provide updated 2022 financial guidance during earnings call."],"consensus_eps_estimate":null,"consensus_eps_actual":9.83,"consensus_revenue_estimate":null,"consensus_revenue_actual":22788000000.0,"consensus_period":"2022-Q2","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":169537423477.71124,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":383239,"accession_number":"0000097745-22-000032","cik":97745,"company_name":"THERMO FISHER SCIENTIFIC INC.","ticker":"TMO","form_type":"8-K","filed_at":"2022-05-19T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Thermo Fisher Scientific reports 2022 annual meeting voting results","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["All 12 director nominees elected; Marc N. Casper received 295.0M for, 28.6M against.","Advisory say-on-pay approved: 285.8M for, 38.2M against, 1.1M abstain.","PwC ratified as auditor for FY2022: 326.2M for, 16.5M against, 0.8M abstain.","Broker non-votes of 18.4M on director elections and say-on-pay proposals."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":169537423477.71124,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":383238,"accession_number":"0000097745-22-000022","cik":97745,"company_name":"THERMO FISHER SCIENTIFIC INC.","ticker":"TMO","form_type":"8-K","filed_at":"2022-04-28T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Thermo Fisher Q1 revenue $11.82B (+19%), adjusted EPS $7.25; raises dividend 15%","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["GAAP EPS $5.61 vs $5.88 last year; adjusted EPS $7.25 vs $7.21.","Core organic growth 16%; COVID-19 testing revenue $1.68B.","Repurchased $2.0B of stock and increased dividend by 15%.","PPD clinical research business integration proceeding smoothly.","Moderna entered 15-year strategic collaboration for mRNA manufacturing."],"consensus_eps_estimate":null,"consensus_eps_actual":5.61,"consensus_revenue_estimate":null,"consensus_revenue_actual":11818000000.0,"consensus_period":"2022-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":169537423477.71124,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":401030,"accession_number":"0000097745-22-000008","cik":97745,"company_name":"THERMO FISHER SCIENTIFIC INC.","ticker":"TMO","form_type":"8-K","filed_at":"2022-02-24T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Thermo Fisher elects Ruby R. Chandy to board; director Thomas J. Lynch to retire at 2022 annual meeting","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Board increased to 13; Ruby R. Chandy elected effective March 1, 2022, term through 2022 annual meeting; serve on Audit Committee.","Thomas J. Lynch (Lead Director since 2020) to retire at 2022 annual meeting; board to reduce to 12 members.","Chandy was President of Industrial Division at Pall Corp; prior roles at Dow Chemical and Rohm and Haas; also on DuPont and Flowserve boards.","Non-management directors receive $125k annual cash retainer; committee chairs get additional $20k-$25k; equity per Compensation Committee."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":169537423477.71124,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":401029,"accession_number":"0000097745-22-000003","cik":97745,"company_name":"THERMO FISHER SCIENTIFIC INC.","ticker":"TMO","form_type":"8-K","filed_at":"2022-02-02T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Thermo Fisher Q4 revenue $10.70B, adj EPS $6.54; full-year rev up 22% to $39.21B","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 GAAP diluted EPS $4.17 (vs $6.24); adjusted EPS $6.54 (vs $7.09); COVID-19 response rev $2.45B.","Full-year GAAP diluted EPS $19.46 (+22%); adjusted EPS $25.13 (+28%); COVID-19 response rev $9.23B.","Base business organic growth 8% in Q4, 14% for full year; acquisitions added 6% and 3%, respectively.","Invested $24B in 2021 strategic acquisitions (PPD, PeproTech); returned $2.4B to shareholders via buybacks and dividends.","2022 financial guidance to be provided during earnings call; no specific numbers in release."],"consensus_eps_estimate":null,"consensus_eps_actual":19.46,"consensus_revenue_estimate":null,"consensus_revenue_actual":39211000000.0,"consensus_period":"2021-FY","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":169537423477.71124,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":401028,"accession_number":"0001193125-22-014316","cik":97745,"company_name":"THERMO FISHER SCIENTIFIC INC.","ticker":"TMO","form_type":"8-K","filed_at":"2022-01-21T23:59:59+00:00","items":["7.01"],"status":"ready","headline":"Thermo Fisher to redeem $350M 3.650% Senior Notes due 2025 on Feb 7, 2022","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["$350M aggregate principal of 3.650% Senior Notes due 2025 to be redeemed on February 7, 2022.","Redemption price set at greater of 100% of principal or discounted present value at comparable Treasury rate plus 25 bps, plus accrued interest.","Redemption funded from cash on hand."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":169537423477.71124,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":401027,"accession_number":"0001104659-22-002262","cik":97745,"company_name":"THERMO FISHER SCIENTIFIC INC.","ticker":"TMO","form_type":"8-K","filed_at":"2022-01-07T23:59:59+00:00","items":["1.01","1.02","2.03","8.01","9.01"],"status":"ready","headline":"Thermo Fisher enters new $5.0B credit facility and expands CP program to $5.0B","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["New $5.0B unsecured five-year revolving credit facility replaces prior $3.0B facility, matures Jan 7, 2027.","Expansion option allows up to $1.0B additional commitments subject to lender consent.","Interest margins: 0.795%-1.300% over Term SOFR (or comparable) plus facility fee 0.080%-0.200%, tied to credit ratings.","Company increases total commercial paper capacity to $5.0B (USCP from $1.5B, ECP from €1.5B) on or about Jan 10, 2022.","Proceeds may be used for working capital, acquisitions, stock repurchases, debt refinancing, and general corporate purposes."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":169537423477.71124,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":419980,"accession_number":"0001193125-21-357356","cik":97745,"company_name":"THERMO FISHER SCIENTIFIC INC.","ticker":"TMO","form_type":"8-K","filed_at":"2021-12-15T23:59:59+00:00","items":["7.01"],"status":"ready","headline":"Thermo Fisher redeems $1.2B 2026 and $750M 2027 notes for ~$1.95B","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Redeems $1.2B of 2.95% Senior Notes due 2026 and $750M of 3.2% Senior Notes due 2027.","Redemption date is December 30, 2021; aggregate redemption price approximately $1.95 billion.","Funding source is cash on hand; redemption prices based on treasury rate plus 25 bps (2026) or 20 bps (2027)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":169537423477.71124,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":419979,"accession_number":"0000950157-21-001239","cik":97745,"company_name":"THERMO FISHER SCIENTIFIC INC.","ticker":"TMO","form_type":"8-K","filed_at":"2021-12-08T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Thermo Fisher completes $17.4B acquisition of clinical research firm PPD, Inc.","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Total consideration $17.4 billion; PPD common stock ceased trading on Nasdaq.","Deal expected to contribute $1.50 to Thermo Fisher's adjusted EPS in 2022.","Synergies of ~$125M by year three: $75M cost, $50M revenue-related.","Thermo Fisher assumes ~$3.0B net debt of PPD, all retired at closing.","PPD to join Laboratory Products and Services Segment."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":169537423477.71124,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":"2021-12-08T23:59:59+00:00|419979"}